Liquid chromatographic - electrospray tandem mass spectrometric method for the quantification of nimodipine in human plasma

Pharmazie

Volumn 61, Issue 10, 2006, Pages 828-834

  Nirogi, Ramakrishna V S ^a   Kandikere, V N ^a   Maurya, S ^a   Mudigonda, K ^a   Boosi, R ^a  

^a SUVEN LIFE SCIENCES LTD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NIMODIPINE;

ARTICLE; BLOOD ANALYSIS; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; NIMODIPINE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; THERAPEUTIC EQUIVALENCY;

EID: 33750320011     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Allen GS, Ahn HS, Preziosi TJ, Batty R (1983) Cerebral artery spasm - a controlled trial of nimodipine in patients with SAH. N Engl J Med 308: 629-624.
2. Aymard G, Cayre-Castel M, Fernandez C, Lacomblez L, Diquet B (1998) High-performance liquid chromatography with ultraviolet and fluorimetric detection for the simultaneous determination of tacrine, nimodipine, and their respective metabolites in the plasma of patients with Alzheimer disease. Ther Drug Monit 20: 422-429.
3. Bailey I, Bell A, Gray J, Gullan R, Heiskanan O, Marks PV et al. (1991) A trial of the effects of nimodipine on outcome after head injury. Acta Neurochir (Wien) 110: 97-105.
4. Blardi P, Urso R, De Lalla A, Volpi L, Perri TD, Auteri A (2002) Nimodipine, drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia. Clin Pharmacol Ther 72: 556-561.
5. Cech NB, Enke CG (2001) Practical implications of some recent studies in electrospray ionization fundamentals. Mass Spectrom Rev 20: 362-387.
6. Fischer C, Schonberger F, Muck W, Heuck K, Eichelbaum M (1993) Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectrometry combined with a stable isotope technique. J Pharma Sci 82: 244-250.
7. Gelmers HJ, Gorter K, DeWeerdt CJ, Wiezer HJ (1988) A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 318: 203-207.
8. Gualano V, Ntsikoussalabongui B, Mignot A, Duvauchelle T, Felices M, Guillaume M, Orlandini B, Holguin JA, Alcaide A (1999) Comparative bioavailability of two oral nimodipine formulations after administration to 24 healthy volunteers. Clin Drug Invest 17: 475-482.
9. Jakobsen P, Mikkelsen EO, Laursen J, Jensen F (1986) Determination of nimodipine by gas chromatography using electron-capture detection: external factors influencing nimodipine concentrations during intravenous administration. J Chromatogr 374: 383-387.
10. Jemal M (2000) High-throughput quantitative bioanalysis by LC/MS/MS. Biomed Chromatogr 14: 422-429.
11. Krol GJ, Noe AJ, Yeh SC, Raemsch KD (1984) Gas and liquid chromatographic analyses of nimodipine calcium antagonist in blood plasma and cerebrospinal fluid. J Chromatogr 305: 105-118.
12. Langley MS, Sorkin E (1989) Nimodipine, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 37: 669-699.
13. Lopez JA, Martinez V, Alonso RM, Jimenez RM (2000) High-performance liquid chromatography with amperometric detection applied to the screening of 1,4-dihydropyridines in human plasma. J Chromatogr A 870: 105-114.
14. Morich FJ, Bieber F, Lewis JM, Kaiter L, Cuttler NR, Escobar JT et al. (1996) Nimodipine in the treatment of probable Alzheimer's disease. Clin Drug Invest 11: 185-195.
15. Mück WM (1995) Enantiospecific determination of nimodipine in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr A 712: 45-53.
16. Niessen WM (2003) Progress in liquid chromatography-mass spectrometry instrumentation and its impact on high-throughput screening. J Chromatogr A 1000: 413-436.
17. Nirogi RVS, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Boosi R, Yerramilli A (2005) Sensitive and selective liquid chromatography-tandem mass spectrometry method for the quantification of azithromycin in human plasma. Anal Chim Acta 553: 1-8.
18. Qian M, Gallo JM (1992) High-performance liquid cromatographic determination of the calcium channel blocker nimodipine in monkey plasma. J Chromatogr 578: 316-320.
19. Qiu F, Chen X, Li X, Zhong D (2004) Determination of nimodipine in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method. J Chromatogr B 802: 291-297.
20. Ramakrishna NVS, Vishwottam KN, Koteshwara M, Manoj S, Santosh M, Varma DP (2005a) Rapid quantification of nebivolol in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J Pharma Biomed Anal 39: 1006-1013.
21. Ramakrishna NVS, Vishwottam KN, Manoj S, Koteshwara M, Santosh M, Chidambara J, Ravi Kumar B (2005b) Liquid chromatography/electrospray ionization mass spectrometry method for the quantification of valproic acid in human plasma. Rapid Commun Mass Spectrom 19: 1970-1978.
22. Ramakrishna NVS, Vishwottam KN, Manoj S, Koteshwara M, Chidambara J, Varma DP (2005c) Validation and application of a high-performance liquid chromatography-tandem mass spectrometry assay for mosapride in human plasma. Biomed Chromatogr. 19: 539-548.
23. Rosseel MT, Bogaert MG, Huyghens L (1990) Determination of the calcium antagonist nimodipine in plasma by capillary gas chromatography and nitrogen detection. J Chromatogr 533: 224-228.
24. US Department of Health and Human Services (2001) Guidance for industry: bioanalytical method validation, Food and Drug Administration, Center for Drug Evaluation and Research, Rock ville, MD.